カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のA型＆B型肝炎ワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Hepatitis A and B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19376）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19376
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のA型＆B型肝炎ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

A型＆B型肝炎ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のA型＆B型肝炎ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

A型＆B型肝炎ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・A型肝炎ワクチン接種、B型肝炎ワクチン接種

用途別セグメントは次のように区分されます。
・政府機関、民間、その他

世界のA型＆B型肝炎ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、LG Life Sciences、Serum Institute

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、A型＆B型肝炎ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なA型＆B型肝炎ワクチンメーカーの企業概要、2019年～2022年までのA型＆B型肝炎ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なA型＆B型肝炎ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別A型＆B型肝炎ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのA型＆B型肝炎ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのA型＆B型肝炎ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびA型＆B型肝炎ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、A型＆B型肝炎ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- A型＆B型肝炎ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：A型肝炎ワクチン接種、B型肝炎ワクチン接種
- 用途別分析（2017年vs2021年vs2028年）：政府機関、民間、その他
- 世界のA型＆B型肝炎ワクチン市場規模・予測
- 世界のA型＆B型肝炎ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、LG Life Sciences、Serum Institute
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：A型肝炎ワクチン接種、B型肝炎ワクチン接種
・用途別分析2017年-2028年：政府機関、民間、その他
・A型＆B型肝炎ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・A型＆B型肝炎ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・A型＆B型肝炎ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・A型＆B型肝炎ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・A型＆B型肝炎ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Hepatitis A and B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hepatitis A and B Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Government Institution accounting for % of the Hepatitis A and B Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatitis A Vaccination segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hepatitis A and B Vaccine include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hepatitis A and B Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatitis A Vaccination
Hepatitis B Vaccination
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global Hepatitis A and B Vaccine market are listed below:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A and B Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A and B Vaccine, with price, sales, revenue and global market share of Hepatitis A and B Vaccine from 2019 to 2022.
Chapter 3, the Hepatitis A and B Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A and B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hepatitis A and B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis A and B Vaccine.
Chapter 13, 14, and 15, to describe Hepatitis A and B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Hepatitis A and B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepatitis A and B Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatitis A Vaccination
1.2.3 Hepatitis B Vaccination
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepatitis A and B Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A and B Vaccine Market Size & Forecast
1.4.1 Global Hepatitis A and B Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hepatitis A and B Vaccine Sales in Volume (2017-2028)
1.4.3 Global Hepatitis A and B Vaccine Price (2017-2028)
1.5 Global Hepatitis A and B Vaccine Production Capacity Analysis
1.5.1 Global Hepatitis A and B Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Hepatitis A and B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis A and B Vaccine Market Drivers
1.6.2 Hepatitis A and B Vaccine Market Restraints
1.6.3 Hepatitis A and B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Hepatitis A and B Vaccine Product and Services
2.1.4 GSK Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Hepatitis A and B Vaccine Product and Services
2.2.4 Merck Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Hepatitis A and B Vaccine Product and Services
2.3.4 Sanofi Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Hepatitis A and B Vaccine Product and Services
2.4.4 Sinovac Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Product and Services
2.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Product and Services
2.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Hepatitis A and B Vaccine Product and Services
2.7.4 KM Biologics Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IMBCAMS
2.8.1 IMBCAMS Details
2.8.2 IMBCAMS Major Business
2.8.3 IMBCAMS Hepatitis A and B Vaccine Product and Services
2.8.4 IMBCAMS Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Convac
2.9.1 Convac Details
2.9.2 Convac Major Business
2.9.3 Convac Hepatitis A and B Vaccine Product and Services
2.9.4 Convac Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Hepatitis A and B Vaccine Product and Services
2.10.4 NCPC Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bio Kangtai
2.11.1 Bio Kangtai Details
2.11.2 Bio Kangtai Major Business
2.11.3 Bio Kangtai Hepatitis A and B Vaccine Product and Services
2.11.4 Bio Kangtai Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Dynavax
2.12.1 Dynavax Details
2.12.2 Dynavax Major Business
2.12.3 Dynavax Hepatitis A and B Vaccine Product and Services
2.12.4 Dynavax Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Hepatitis A and B Vaccine Product and Services
2.13.4 Hissen Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 LG Life Sciences
2.14.1 LG Life Sciences Details
2.14.2 LG Life Sciences Major Business
2.14.3 LG Life Sciences Hepatitis A and B Vaccine Product and Services
2.14.4 LG Life Sciences Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Serum Institute
2.15.1 Serum Institute Details
2.15.2 Serum Institute Major Business
2.15.3 Serum Institute Hepatitis A and B Vaccine Product and Services
2.15.4 Serum Institute Hepatitis A and B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hepatitis A and B Vaccine Breakdown Data by Manufacturer
3.1 Global Hepatitis A and B Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hepatitis A and B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hepatitis A and B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Hepatitis A and B Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Hepatitis A and B Vaccine Manufacturer Market Share in 2021
3.5 Global Hepatitis A and B Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hepatitis A and B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hepatitis A and B Vaccine Market Size by Region
4.1.1 Global Hepatitis A and B Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Hepatitis A and B Vaccine Revenue by Region (2017-2028)
4.2 North America Hepatitis A and B Vaccine Revenue (2017-2028)
4.3 Europe Hepatitis A and B Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Hepatitis A and B Vaccine Revenue (2017-2028)
4.5 South America Hepatitis A and B Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Hepatitis A and B Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hepatitis A and B Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Hepatitis A and B Vaccine Revenue by Type (2017-2028)
5.3 Global Hepatitis A and B Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hepatitis A and B Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Hepatitis A and B Vaccine Revenue by Application (2017-2028)
6.3 Global Hepatitis A and B Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hepatitis A and B Vaccine Sales by Type (2017-2028)
7.2 North America Hepatitis A and B Vaccine Sales by Application (2017-2028)
7.3 North America Hepatitis A and B Vaccine Market Size by Country
7.3.1 North America Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Hepatitis A and B Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hepatitis A and B Vaccine Sales by Type (2017-2028)
8.2 Europe Hepatitis A and B Vaccine Sales by Application (2017-2028)
8.3 Europe Hepatitis A and B Vaccine Market Size by Country
8.3.1 Europe Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Hepatitis A and B Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hepatitis A and B Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Hepatitis A and B Vaccine Market Size by Region
9.3.1 Asia-Pacific Hepatitis A and B Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hepatitis A and B Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hepatitis A and B Vaccine Sales by Type (2017-2028)
10.2 South America Hepatitis A and B Vaccine Sales by Application (2017-2028)
10.3 South America Hepatitis A and B Vaccine Market Size by Country
10.3.1 South America Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Hepatitis A and B Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hepatitis A and B Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Hepatitis A and B Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Hepatitis A and B Vaccine Market Size by Country
11.3.1 Middle East & Africa Hepatitis A and B Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hepatitis A and B Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hepatitis A and B Vaccine
12.3 Hepatitis A and B Vaccine Production Process
12.4 Hepatitis A and B Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hepatitis A and B Vaccine Typical Distributors
13.3 Hepatitis A and B Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Hepatitis A and B Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hepatitis A and B Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Hepatitis A and B Vaccine Product and Services
Table 6. GSK Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Hepatitis A and B Vaccine Product and Services
Table 10. Merck Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Hepatitis A and B Vaccine Product and Services
Table 14. Sanofi Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sinovac Basic Information, Manufacturing Base and Competitors
Table 16. Sinovac Major Business
Table 17. Sinovac Hepatitis A and B Vaccine Product and Services
Table 18. Sinovac Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
Table 20. Zhejiang Pukang Major Business
Table 21. Zhejiang Pukang Hepatitis A and B Vaccine Product and Services
Table 22. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 24. Changchun Institute of Biological Major Business
Table 25. Changchun Institute of Biological Hepatitis A and B Vaccine Product and Services
Table 26. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 28. KM Biologics Major Business
Table 29. KM Biologics Hepatitis A and B Vaccine Product and Services
Table 30. KM Biologics Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IMBCAMS Basic Information, Manufacturing Base and Competitors
Table 32. IMBCAMS Major Business
Table 33. IMBCAMS Hepatitis A and B Vaccine Product and Services
Table 34. IMBCAMS Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Convac Basic Information, Manufacturing Base and Competitors
Table 36. Convac Major Business
Table 37. Convac Hepatitis A and B Vaccine Product and Services
Table 38. Convac Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. NCPC Basic Information, Manufacturing Base and Competitors
Table 40. NCPC Major Business
Table 41. NCPC Hepatitis A and B Vaccine Product and Services
Table 42. NCPC Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 44. Bio Kangtai Major Business
Table 45. Bio Kangtai Hepatitis A and B Vaccine Product and Services
Table 46. Bio Kangtai Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Dynavax Basic Information, Manufacturing Base and Competitors
Table 48. Dynavax Major Business
Table 49. Dynavax Hepatitis A and B Vaccine Product and Services
Table 50. Dynavax Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hissen Basic Information, Manufacturing Base and Competitors
Table 52. Hissen Major Business
Table 53. Hissen Hepatitis A and B Vaccine Product and Services
Table 54. Hissen Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 56. LG Life Sciences Major Business
Table 57. LG Life Sciences Hepatitis A and B Vaccine Product and Services
Table 58. LG Life Sciences Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 60. Serum Institute Major Business
Table 61. Serum Institute Hepatitis A and B Vaccine Product and Services
Table 62. Serum Institute Hepatitis A and B Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Hepatitis A and B Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 64. Global Hepatitis A and B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Hepatitis A and B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Hepatitis A and B Vaccine Production Capacity by Company, (Units): 2020 VS 2021
Table 67. Head Office and Hepatitis A and B Vaccine Production Site of Key Manufacturer
Table 68. Hepatitis A and B Vaccine New Entrant and Capacity Expansion Plans
Table 69. Hepatitis A and B Vaccine Mergers & Acquisitions in the Past Five Years
Table 70. Global Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 71. Global Hepatitis A and B Vaccine Sales by Region (2023-2028) & (Units)
Table 72. Global Hepatitis A and B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Hepatitis A and B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 75. Global Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 76. Global Hepatitis A and B Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Hepatitis A and B Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Hepatitis A and B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Hepatitis A and B Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 81. Global Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 82. Global Hepatitis A and B Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Hepatitis A and B Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Hepatitis A and B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Hepatitis A and B Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 87. North America Hepatitis A and B Vaccine Sales by Country (2023-2028) & (Units)
Table 88. North America Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Hepatitis A and B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 91. North America Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 92. North America Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 93. North America Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 94. Europe Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 95. Europe Hepatitis A and B Vaccine Sales by Country (2023-2028) & (Units)
Table 96. Europe Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Hepatitis A and B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 99. Europe Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 100. Europe Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 101. Europe Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 102. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 103. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2023-2028) & (Units)
Table 104. Asia-Pacific Hepatitis A and B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Hepatitis A and B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 107. Asia-Pacific Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 108. Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 109. Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 110. South America Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 111. South America Hepatitis A and B Vaccine Sales by Country (2023-2028) & (Units)
Table 112. South America Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Hepatitis A and B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 115. South America Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 116. South America Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 117. South America Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 118. Middle East & Africa Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 119. Middle East & Africa Hepatitis A and B Vaccine Sales by Region (2023-2028) & (Units)
Table 120. Middle East & Africa Hepatitis A and B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Hepatitis A and B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 123. Middle East & Africa Hepatitis A and B Vaccine Sales by Type (2023-2028) & (Units)
Table 124. Middle East & Africa Hepatitis A and B Vaccine Sales by Application (2017-2022) & (Units)
Table 125. Middle East & Africa Hepatitis A and B Vaccine Sales by Application (2023-2028) & (Units)
Table 126. Hepatitis A and B Vaccine Raw Material
Table 127. Key Manufacturers of Hepatitis A and B Vaccine Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Hepatitis A and B Vaccine Typical Distributors
Table 131. Hepatitis A and B Vaccine Typical Customers
List of Figures
Figure 1. Hepatitis A and B Vaccine Picture
Figure 2. Global Hepatitis A and B Vaccine Revenue Market Share by Type in 2021
Figure 3. Hepatitis A Vaccination
Figure 4. Hepatitis B Vaccination
Figure 5. Global Hepatitis A and B Vaccine Revenue Market Share by Application in 2021
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Hepatitis A and B Vaccine Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 10. Global Hepatitis A and B Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Hepatitis A and B Vaccine Sales (2017-2028) & (Units)
Figure 12. Global Hepatitis A and B Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global Hepatitis A and B Vaccine Production Capacity (2017-2028) & (Units)
Figure 14. Global Hepatitis A and B Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Hepatitis A and B Vaccine Market Drivers
Figure 16. Hepatitis A and B Vaccine Market Restraints
Figure 17. Hepatitis A and B Vaccine Market Trends
Figure 18. Global Hepatitis A and B Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Hepatitis A and B Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Hepatitis A and B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Hepatitis A and B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Hepatitis A and B Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Hepatitis A and B Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Hepatitis A and B Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Hepatitis A and B Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Hepatitis A and B Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Hepatitis A and B Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Hepatitis A and B Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Hepatitis A and B Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Hepatitis A and B Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Hepatitis A and B Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Hepatitis A and B Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Hepatitis A and B Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Hepatitis A and B Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Hepatitis A and B Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Hepatitis A and B Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Hepatitis A and B Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Hepatitis A and B Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Hepatitis A and B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Hepatitis A and B Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Hepatitis A and B Vaccine
Figure 78. Hepatitis A and B Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のB型肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のA型肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のA型肝炎ワクチン接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19376 )"世界のA型＆B型肝炎ワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Hepatitis A and B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。